Skip to content

High uptake of HIV self-testing by men who have sex with men and transgender women in Burma

High uptake of HIV self-testing by men who have sex with men and transgender women in Burma

Powerful new PrEP and treatment drug should be effective as a small weekly pill

Martin Markowitz at CROI 2018. Photo by Liz Highleyman.

Another possible case of PrEP 'breakthrough' infection reported

How much 'PrEP-resistant' HIV is out there?

How much 'PrEP-resistant' HIV is out there?

Ibalizumab, active against highly resistant HIV, now approved in US

Ibalizumab, active against highly resistant HIV, now approved in US

Statin users have lower rates of many types of cancer

Roger Bedimo presenting at CROI 2018. Photo by Liz Highleyman.

The vaginal ring: more HOPE to the DREAM? Higher adherence and better effectiveness seen in open-label ring studies

Jared Baeten and Zeda Rosenberg at CROI 2018. Photo by Liz Highleyman.

Efavirenz may undermine effectiveness of the vaginal ring contraceptive

Kimberly Scarsi at CROI 2018. Photo by Liz Highleyman.

Average time from HIV diagnosis to treatment fell to six days in 2016 in San Francisco